NON SMALL CELL LUNG
Clinical trials for NON SMALL CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung cancer patients whose current drug stops working
Disease control OngoingThis study tests whether adding savolitinib to osimertinib works better than chemotherapy for people with a certain type of advanced lung cancer (EGFR-mutated, MET-positive) that has stopped responding to osimertinib. About 345 adults will be randomly assigned to receive either t…
Matched conditions: NON SMALL CELL LUNG
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Real-World data reveals how lung cancer drug lorlatinib performs outside the lab
Knowledge-focused OngoingThis study looks at how patients with ALK-positive advanced non-small cell lung cancer respond to the drug lorlatinib when used as their first treatment in real-world settings. Researchers will analyze data from 200 patients in a U.S. database to see how long they stay on the dru…
Matched conditions: NON SMALL CELL LUNG
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC